Estados Unidos · Plataformas y datos · TradingView

HC Wainwright & Co. upgrades Inovio Pharmaceuticals to Buy from Neutral, sets price target at $5

Publicado por TradingView · Estados Unidos hace 1 d

HC Wainwright & Co. upgraded Inovio Pharmaceuticals to Buy from Neutral and set a price target of $5.The price target implies an upside of 730.0% from the Oct 30 close of…

Leer el artículo completo en TradingView Inicie sesión para guardar

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.tradingview.com)

HC Wainwright & Co. upgrades Inovio Pharmaceuticals to Buy from Neutral, sets price target at $5

También te puede interesar

Here’s why Palantir’s stock is down despite a ‘bombastic’ quarter

Apple anticipates December quarter revenue growth of 7%-10% amid supply constraints and higher memory costs

Valaris (NYSE:VAL) Releases Earnings Results, Misses Expectations By $0.40 EPS

SK Hynix rejected below Ichimoku cloud: Live levels

Stock market after midterm elections: What S&P 500 history shows

Colony Bankcorp Earnings Call Signals Merger-Driven Growth

HC Wainwright & Co. upgrades Inovio Pharmaceuticals to Buy from Neutral, sets price target at $5

Compartir

También te puede interesar

Here’s why Palantir’s stock is down despite a ‘bombastic’ quarter

Apple anticipates December quarter revenue growth of 7%-10% amid supply constraints and higher memory costs

Valaris (NYSE:VAL) Releases Earnings Results, Misses Expectations By $0.40 EPS

SK Hynix rejected below Ichimoku cloud: Live levels

Stock market after midterm elections: What S&P 500 history shows

Colony Bankcorp Earnings Call Signals Merger-Driven Growth